Development of new screening system for Alzheimer disease, in vitro Abeta sink assay, to identify the dissociation of soluble Abeta from fibrils.
about
Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factorsUltrasound attacks Alzheimer's disease?Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer's disease.
P2860
Development of new screening system for Alzheimer disease, in vitro Abeta sink assay, to identify the dissociation of soluble Abeta from fibrils.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Development of new screening s ...... of soluble Abeta from fibrils.
@en
Development of new screening s ...... of soluble Abeta from fibrils.
@nl
type
label
Development of new screening s ...... of soluble Abeta from fibrils.
@en
Development of new screening s ...... of soluble Abeta from fibrils.
@nl
prefLabel
Development of new screening s ...... of soluble Abeta from fibrils.
@en
Development of new screening s ...... of soluble Abeta from fibrils.
@nl
P2093
P1476
Development of new screening s ...... of soluble Abeta from fibrils.
@en
P2093
Akio Fukumori
Daisuke Takeuchi
Hitomi Kurinami
Hizuki Hamada
Masatoshi Takeda
Masayuki Miyasaka
Munehisa Shimamura
Naoyuki Sato
Ryuichi Morishita
Takahisa Taguchi
P304
P356
10.1016/J.NBD.2005.12.010
P577
2006-02-20T00:00:00Z